NeuroOne projects FY 2025 revenue growth of up to 190% with Zimmer Biomet partnership
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Management View CEO Dave Rosa highlighted the strong performance of the OneRF ablation system, which is the first FDA-cleared product ...
Hosted on MSN54m
Stocks Sink and Bond Yields Spike on Strong CPI
The S&P 500 Index ($SPX) (SPY) today is down -0.91%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.92%, and the ...